Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
39 Leser
Artikel bewerten:
(0)

RESOLVE:The National Infertility Association Urges Passage of the Family Act

SAN DIEGO, Oct. 23, 2012 /PRNewswire/ --RESOLVE: The National Infertility Association urged patients and the medical community to call upon Congress to pass the aptly named Family Act, S 965/HR 3522. This important call to action took place during the 68th Annual Meeting for the American Society for Reproductive Medicine (ASRM) in San Diego, CA. The Family Act is a federal bill which will create a tax credit for the out-of-pocket costs associated with in vitro fertilization (IVF) and fertility preservation after a cancer diagnosis.

"The Family Act is important to people diagnosed with infertility and those that want to preserve their fertility after being diagnosed with cancer. RESOLVE continues to mobilize doctors, patients, and the entire infertility community to ask their elected to support this legislation," said Barbara Collura, President of RESOLVE, speaking at a briefing at the ASRM meeting.

Dr. Arlene Morales shared her experience as a Reproductive Endocrinologist helping patients navigate their family building journey. "Every day I see patients struggle with the cost associated with the most effective course of treatment for their disease because so many insurance plans do not cover IVF. As their physicians, Dr. Wendy Shelly and I are proud to support the Family Act knowing this bill will lessen their financial burden," said Dr. Morales, Medical Director for Fertility Specialists Medical Group located in San Diego, CA.

Congressman Brian Bilbray (R-CA), represents the 50th Congressional District in California, spoke about his support of the bill and urged anyone who cares about someone facing infertility to talk to their members of Congress about the Family Act. "As a father of three grown daughters, I have heard them talk about friends trying, unsuccessfully, to have a child. Infertility affects more young women than people realize. According to recent statistics, it affects approximately one-in-10 women between the prime childbearing ages of 20 to 35. For many, the devastating news of infertility is followed by the shocking cost of treatment. While a tax credit cannot replace the total cost of treatment, it can provide some help to young women trying to conceive."

Leigh Cook, an infertility patient from San Diego, CA, described herself as a "woman who does not give up hope." Cook and her husband spent years trying less effective medical procedures that did not result in a successful pregnancy before turning to in vitro fertilization and paying out of pocket for the treatment because her insurance did not cover the costs. "The Family Act would have been a catalyst for us to pursue the best options for our medical care much earlier in the process," said Cook.

Dr. Glenn Schattman, President of the Society for Assisted Reproductive Technology, recognized the important role that physicians play in supporting this bill. "The Family Act is an example of social good, and the Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine support this bill."

One in eight U.S. couples of childbearing age is diagnosed with infertility. For more information, visit www.resolve.org/taxcredit or www.resolve.org.

About RESOLVE: The National Infertility Association: Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for men and women experiencing infertility or other reproductive disorders. One in eight U.S. couples of childbearing age is diagnosed with infertility. RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options. For more information, visit www.RESOLVE.org.

RESOLVE Contact:
Andy Schwarz
703.556.7172
aschwarz@resolve.org

SOURCE RESOLVE: The National Infertility Association

© 2012 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.